Indicative Announcement on the Restricted Exercise Period under the 2022 Stock Option Incentive Plan
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600572)"Zhejiang CONBA Pharmaceutical Co., Ltd."Indicative Announcement on the Restricted Exercise Period under the 2022 Stock Option Incentive Plan
Filed with SSE · Stock code 600572 · · 1 page · Chinese
Summary by 6ix AI
The company assures that the announcement is accurate and complete, adhering to relevant regulations and guidelines.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Zhejiang CONBA Pharmaceutical Co., Ltd. on 6ix
Story so far
- (600572)"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Self-exercise Results in Q3 2026 under the Stock Option Incentive Plan and Share Changes
- Indicative Announcement on the Restricted Exercise Period under the 2022 Stock Option Incentive Plan
- Announcement on Self-exercise Results of Stock Option Incentive Plan and Share Changes for Q2 2026
Earlier from Zhejiang CONBA Pharmaceutical
- (600572)"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on the Shareholding Reduction Plan of Shareholder through Call Auction
- (600572)"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Self-exercise Results in Q3 2026 under the Stock Option Incentive Plan and Share Changes
- (600572)"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Receipt of Drug Registration Certificate for Dapoxetine Hydrochloride Tablets by Subsidiary
- Announcement on Resolutions of the 21st (Extraordinary) Meeting of the 11th Board of Directors
- Announcement on Convening the 2026 Semi-annual Performance Briefing
Follow Zhejiang CONBA Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang CONBA Pharmaceutical